StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Ashish Bahety, Profitmart Securities

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byAshish Bahety, Profitmart SecuritiesHorizon: NA (inferred 1–3 months)30 Jun 2026via CNBC Awaaz.

Entry₹1,891.9Inferred
Target₹1,960
Total upside +3.60% (call closed)
Stop loss₹1,860-1.69% risk
Exit₹1,86030 Jun 2026, 3:09 pm
Stop-loss hit-1.69%
Follow Ashish Bahety for new calls(34% target hit, 47 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 3 active Short-term calls on SUNPHARMASee 43 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 30 Jun 2026
2 supporting0 opposing
Supports the BUY call (2)

5 advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · adjacent horizon·29 Jun · yesterday

Sun Pharma has entered into an agreement to acquire 100% outstanding shares of Innovcare Lifesciences Private Limited for approximately Rs 271.2 Crores. Innovcare is engaged in marketing, distribution

BSE · Company Update·20 Jun · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Ashish Bahety, Profitmart Securities

Every call and its outcome